Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis
European Journal of Haematology · 2025-03 · 114 (3) · 429-435
DOI: 10.1111/ejh.14350 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Haematology, online erschienen am 14.11.2024. Verfasst von Kaiya Hassan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ochsner Medical Center, New Orleans, USA. Hauptthemen laut MEDLINE: Thrombocytopenia, Heparin, Anticoagulants, Warfarin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
No existing studies compare oral anticoagulants to treat heparin‐induced thrombocytopenia with or without thrombosis (HIT/HITT). This retrospective study evaluated thrombotic and bleeding outcomes in adults treated for HIT/HITT with a direct oral anticoagulant (DOAC) or warfarin between 2012 and 2023 within the Ochsner Health System. Patients with mechanical heart valves, valvular atrial fibrillation, antiphospholipid syndrome, active malignancy, or venous thromboembolism (VTE) within the previous 6 months were excluded. The primary outcome was a composite of new or progressive VTE or arterial thromboembolism. Secondary outcomes included major and clinically relevant non‐major bleeding, duration of hospitalization, time to platelet recovery, and incidence of skin necrosis, gangrene, and amputation. Forty‐nine patients receiving a DOAC and 30 patients receiving warfarin were included. Baseline characteristics were similar between cohorts. There were non‐statistically significant increased rates of both the primary outcome (8.9% vs. 4.3%, p = 0.65) and the composite bleeding outcome (32.7% vs. 23.3%, p = 0.37) in the DOAC cohort. Larger, prospective studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ochsner Medical Center, New Orleans, USA.
- Xavier University, New Orleans, USA.
ORCID-Profile: Kaiya Hassan, Eric Coons
Zitieren
APA
Hassan, K., Kinan, R., Casey, A., Dermady, M., Mizuki, B., Stanilova, K., Savage, H., Yuan, H., Hillis, E., Bertaut, C., Guillory, T., & Coons, E. (2025). Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis. European Journal of Haematology, 114(3), 429-435. https://doi.org/10.1111/ejh.14350
Vancouver
Hassan K, Kinan R, Casey A, Dermady M, Mizuki B, Stanilova K, et al. Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis. European Journal of Haematology. 2025;114(3):429-435. doi:10.1111/ejh.14350
BibTeX
@article{Hassan2025,
author = {Hassan, Kaiya and Kinan, Robert and Casey, Ashley and Dermady, Miranda and Mizuki, Britta and Stanilova, Katerina and Savage, Heather and Yuan, Helen and Hillis, Emma and Bertaut, Connor and Guillory, Taylor and Coons, Eric},
title = {Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin‐Induced Thrombocytopenia or Heparin‐Induced Thrombocytopenia With Thrombosis},
journal = {European Journal of Haematology},
year = {2025},
volume = {114},
number = {3},
pages = {429--435},
doi = {10.1111/ejh.14350}
}
EUVIMED